Results 301 to 310 of about 19,492,817 (319)
Some of the next articles are maybe not open access.
Therapie, 2008
BACKGROUND: Basal cell carcinoma (BCC) is the most prevalent cancer. A minority of BCCs have an aggressive behaviour (laBCC) and may require hedgehog pathway inhibitors such as sonidegib as its treatment. OBJECTIVE: To describe the use of sonidegib in a large number of patients and provide more data on its real-life efficacy and safety profile. METHODS:
Moreno-Arrones OM +20 more
+14 more sources
BACKGROUND: Basal cell carcinoma (BCC) is the most prevalent cancer. A minority of BCCs have an aggressive behaviour (laBCC) and may require hedgehog pathway inhibitors such as sonidegib as its treatment. OBJECTIVE: To describe the use of sonidegib in a large number of patients and provide more data on its real-life efficacy and safety profile. METHODS:
Moreno-Arrones OM +20 more
+14 more sources
Boletin de la Sociedad Castellonense de Cultura. Sociedad Castellonense de Cultura, 1976
+6 more sources
+6 more sources

